Studies related to Symptoms of Schizophrenia and CBD

Cannabidiol (CBD) As An Adjunctive Therapy In Schizophrenia: A Multicenter Randomized Controlled Trial

Effect Decrease
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 88
Gender n/a

The Effects Of Cannabidiol (CBD) On Cognition And Symptoms In Outpatients With Chronic Schizophrenia A Randomized Placebo Controlled Trial

Effect None
Trial Design Randomized trial
Trial Length n/a
Number of Subjects 36
Gender n/a